A third dose SARS‑CoV‑2 BNT162b2 mRNA vaccine results in improved immune response in hemodialysis patients

Jan Melin, Maria K. Svensson, Bo Albinsson, Ola Winqvist, Karlis Pauksens

Open source

DOI
10.48101/ujms.v127.8959
Published
2022-10-13
Container
Upsala Journal of Medical Sciences
Publisher
Uppsala Medical Society
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.48101/ujms.v127.8959,
  title = {A third dose SARS‑CoV‑2 BNT162b2 mRNA vaccine results in improved immune response in hemodialysis patients},
  author = {Jan Melin and Maria K. Svensson and Bo Albinsson and Ola Winqvist and Karlis Pauksens},
  year = {2022},
  journal = {Upsala Journal of Medical Sciences},
  doi = {10.48101/ujms.v127.8959},
  url = {https://doi.org/10.48101/ujms.v127.8959}
}

RIS

TY  - JOUR
TI  - A third dose SARS‑CoV‑2 BNT162b2 mRNA vaccine results in improved immune response in hemodialysis patients
AU  - Jan Melin
AU  - Maria K. Svensson
AU  - Bo Albinsson
AU  - Ola Winqvist
AU  - Karlis Pauksens
PY  - 2022
JO  - Upsala Journal of Medical Sciences
DO  - 10.48101/ujms.v127.8959
UR  - https://doi.org/10.48101/ujms.v127.8959
ER  - 

APA

Melin, J., Svensson, M. K., Albinsson, B., Winqvist, O., & Pauksens, K. (2022). A third dose SARS‑CoV‑2 BNT162b2 mRNA vaccine results in improved immune response in hemodialysis patients. Upsala Journal of Medical Sciences. https://doi.org/10.48101/ujms.v127.8959

Source records